Literature DB >> 21419804

Cognitive and locomotor/exploratory behavior after chronic exercise in the olfactory bulbectomy animal model of depression.

Jacqueline Van Hoomissen1, Julie Kunrath, Renee Dentlinger, Andrew Lafrenz, Mark Krause, Afaf Azar.   

Abstract

Despite the evidence that exercise improves cognitive behavior in animal models, little is known about these beneficial effects in animal models of pathology. We examined the effects of activity wheel (AW) running on contextual fear conditioning (CFC) and locomotor/exploratory behavior in the olfactory bulbectomy (OBX) model of depression, which is characterized by hyperactivity and changes in cognitive function. Twenty-four hours after the conditioning session of the CFC protocol, the animals were tested for the conditioned response in a conditioned and a novel context to test for the effects of both AW and OBX on CFC, but also the context specificity of the effect. OBX reduced overall AW running behavior throughout the experiment, but increased locomotor/exploratory behavior during CFC, thus demonstrating a context-dependent effect. OBX animals, however, displayed normal CFC behavior that was context-specific, indicating that aversively conditioned memory is preserved in this model. AW running increased freezing behavior during the testing session of the CFC protocol in the control animals but only in the conditioned context, supporting the hypothesis that AW running improves cognitive function in a context-specific manner that does not generalize to an animal model of pathology. Blood corticosterone levels were increased in all animals at the conclusion of the testing sessions, but levels were higher in AW compared to sedentary groups indicating an effect of exercise on neuroendocrine function. Given the differential results of AW running on behavior and neuroendocrine function after OBX, further exploration of the beneficial effects of exercise in animal models of neuropathology is warranted.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419804     DOI: 10.1016/j.bbr.2011.03.017

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

2.  Fatty acids rehabilitated long-term neurodegenerative: like symptoms in olfactory bulbectomized rats.

Authors:  Shlomo Yehuda; Sharon Rabinovitz
Journal:  J Neural Transm (Vienna)       Date:  2014-10-08       Impact factor: 3.575

3.  Exercise-induced stress resistance is independent of exercise controllability and the medial prefrontal cortex.

Authors:  Benjamin N Greenwood; Katie G Spence; Danielle M Crevling; Peter J Clark; Wendy C Craig; Monika Fleshner
Journal:  Eur J Neurosci       Date:  2012-11-04       Impact factor: 3.386

4.  Voluntary exercise offers anxiolytic potential and amplifies galanin gene expression in the locus coeruleus of the rat.

Authors:  Natale R Sciolino; Rodney K Dishman; Philip V Holmes
Journal:  Behav Brain Res       Date:  2012-05-09       Impact factor: 3.332

Review 5.  Sex differences in resilience: Experiential factors and their mechanisms.

Authors:  Isabella P Fallon; Margaret K Tanner; Benjamin N Greenwood; Michael V Baratta
Journal:  Eur J Neurosci       Date:  2019-12-20       Impact factor: 3.386

6.  Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.

Authors:  Shvetank Bhatt; Radhakrishnan Mahesh; Thangaraj Devadoss; Ankur Kumar Jindal
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

7.  Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n).

Authors:  R Mahesh; S Bhatt; T Devadoss; Ak Jindal; Bk Gautam; Dk Pandey
Journal:  J Young Pharm       Date:  2012-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.